Header cover image
  • Investing Ideas
  • Saudi Arabian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Saudi Arabian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Middle East Pharmaceutical Industries

Market Cap: ر.س2.1b

Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.

4016

ر.س102.50

7D

4.9%

1Y

-18.8%